# Cupid: how the business works

> For learning only. Cityfort is not a SEBI-registered adviser and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

Cupid Limited · NSE: CUPID · BSE: 530843 · Sector: Fast Moving Consumer Goods

Updated for Q2 FY27 · checked 12 Nov 2026

This is the plain-text version of https://cityfort.in/stocks/cupid. Source ids in [brackets] refer to the list at the end. Credit: "Cityfort, Cupid: how the business works", with the page URL.

## In short

Health programmes and buyers abroad, and shops in India, pay Cupid for condoms and personal-care products; materials and bought-in goods take ₹37.8 of every ₹100 that comes in, and ₹27.7 is kept as profit.

- Exports were 59.3% of FY26 product sales. In H1 FY27 the company says India was 66.6% of its sales.
- Since Jan 2026 it has committed ₹331.53 crore to warrants of Baazar Style Retail, a listed retailer; the company said on 11 Nov 2026 that its products will be sold in 290+ Style Baazar stores.

## Key facts

**What does Cupid do?**

Cupid Limited makes male and female condoms at its plant in Sinnar, Nashik. It also sells diagnostic test kits, lubricants, deodorants and perfumes. Its FY26 revenue from operations was ₹357.71 crore. [S1, S14, S8]

**How does Cupid make money?**

Cupid earns money by selling products. In FY26 male condoms were 51.6% of Cupid's product sales, deodorants and other new FMCG products 24.0%, female condoms 17.3% and diagnostic kits and lubricants 7.1%, by the company's own figures. [S8]

**Who are Cupid's customers?**

Cupid sells abroad to national health programmes, UN agencies and procurers such as UNFPA and PFSCM, NGOs and private-label brands. In India it sells through wholesalers and retailers. Exports were 59.3% of Cupid's FY26 product sales. [S1, S7]

**How big is Cupid?**

Cupid's FY26 revenue from operations was ₹357.71 crore and its profit ₹108.26 crore, against ₹183.52 crore and ₹40.93 crore in FY25. In the six months to 30 Sep 2026 (H1 FY27) Cupid's revenue was ₹342.58 crore and profit ₹100.39 crore. [S14, S18, S12]

**Who owns Cupid?**

On 30 Sep 2026 Cupid's promoter group owned 47.69%: Aditya Kumar Halwasiya 34.71%, Columbia Petro Chem Pvt Ltd 12.95% and Ekta Halwasiya 0.03%. Foreign portfolio investors held 4.69%, Indian institutions 1.20% and other shareholders 46.42%. [S27]

**Where does Cupid make its products?**

Cupid makes condoms at one plant in Sinnar, Nashik, with capacity for 480 million male and 52 million female condoms a year. In FY26, 77.55% of Cupid's turnover was from goods it made and the rest from goods it bought and resold. [S6, S1]

**Why did Cupid's share count change?**

Cupid's shares were split 10 for 1 with a 1:1 bonus (allotted 8 Apr 2024) and then given a 4:1 bonus (record date 9 Mar 2026). Cupid's share count rose from about 1.34 crore to 134.47 crore shares. [S37, S56, S47, S27]

## What does Cupid sell?

Cupid makes condoms for health programmes around the world and sells its own brand in India. It also sells diagnostic test kits and lubricants, and a fast-growing range of deodorants, perfumes and personal-care products in Indian shops. It reports one business segment, "Personal care".

- **Male condoms:** Latex condoms in different textures, made at Sinnar. ₹181.11 crore, 51.6% of FY26 product sales by the company's figures. [S8, S1]
- **Female condoms:** Pre-qualified by WHO/UNFPA, the UN's quality check for products bought by health programmes. ₹60.72 crore, 17.3% of FY26 product sales. [S8, S7]
- **Diagnostic kits and lubricants:** In-vitro diagnostic (IVD) test kits, such as for HIV, syphilis, pregnancy and hepatitis B, and water-based lubricants. ₹24.97 crore, 7.1% of FY26 product sales; four kits got EU CE marking in FY26. [S8, S1, S10]
- **Deodorants, perfumes and personal care:** The company's "new FMCG" range for Indian shops: deodorants, pocket perfumes, face wash, hair-removal sprays and more. ₹84.26 crore, 24.0% of FY26 product sales. [S8, S6]

## Who pays Cupid?

- **Buyers outside India (59.3% of revenue):** National health programmes (such as South Africa's 2025–30 programme), UN agencies and procurers (UNFPA, PFSCM, the Global Fund), NGOs (MSI, PSI, IDA Foundation) and private-label brands. Exports were ₹208.13 crore in FY26. [S1, S7]
- **Buyers in India (40.7% of revenue):** Wholesalers, retailers, modern trade, organised retail chains and pharmacies selling Cupid-brand condoms, deodorants and perfumes. India sales were ₹142.86 crore in FY26. [S1, S6]
- **Customer concentration:** Shares are of FY26 sale of products (₹350.99 crore). Cupid has not published a large-customer table since FY24. In FY24 three export customers, listed by country (Tanzania, South Africa, Hong Kong), paid ₹93.86 crore, 54.7% of revenue as restated; Tanzania alone was 27.3%. The FY26 annual report names "customer and tender concentration in the institutional business" as a risk. [S1, S3]

## Where the money went (FY26)

1. Buyers paid Cupid ₹357.71 crore in FY26 for condoms, kits and personal-care products.
2. Other income added ₹33.69 crore, including ₹18.01 crore of interest and an ₹11.64 crore fair-value gain on investments.
3. Materials and goods bought for resale, net of stock built up, took ₹148.14 crore; staff took ₹31.82 crore.
4. Other running costs took ₹61.01 crore, interest and depreciation ₹7.93 crore, and tax ₹34.23 crore.
5. What was left, ₹108.26 crore, was profit.

Sources: S14, S1.

## Key numbers by year (₹ crore)

Financials: standalone, ₹ crore. Financial year runs April to March (March year end). — = not shown on the page.

| Year | Revenue | EBITDA | EBITDA margin | Net profit | Net margin | EPS (₹ per share) | Operating cash flow | Capital spending | Free cash flow | Sources |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| FY22 | 132.73 | 22.99 | 17.3% | 17.28 | 13.0% | 0.13 | 10.24 | 8.64 | 1.6 | S24, S4 |
| FY23 | 159.33 | 41.31 | 25.9% | 31.58 | 19.8% | 0.24 | 32.71 | 2.54 | 30.17 | S23, S4 |
| FY24 (restated) | 171.71 | 50.72 | 29.5% | 39.85 | 23.2% | 0.3 | 7.84 | 89.39 | −81.55 | S2, S22, S3 |
| FY25 | 183.52 | 41.77 | 22.8% | 40.93 | 22.3% | 0.3 | −11.14 | 19.46 | −30.6 | S18, S2, S1 |
| FY26 | 357.71 | 116.74 | 32.6% | 108.26 | 30.3% | 0.81 | 46.12 | 24.69 | 21.43 | S14, S1 |

- EBITDA = profit before interest, tax and wear-and-tear of assets.
- Net profit is the share belonging to the company's owners.

## Balance sheet (as of 30 Sep 2026, ₹ crore)

On 30 Sep 2026 Cupid owed ₹113.66 crore including leases and held ₹16.75 crore of cash and bank balances; on 31 Mar 2026 it held ₹186.45 crore against ₹56.38 crore owed. [S5, S12, S1, S6]

| Item | Value |
| --- | --- |
| Total debt | 113.66 |
| Cash and investments | 16.75 |
| Net debt (debt minus cash) | 96.91 |
| Net worth (shareholders' money) | 562.92 |
| Debt to equity (times) | 0.2 |

- Debt here is borrowings of ₹107.45 crore plus lease liabilities of ₹6.22 crore (₹113.66 crore on unrounded figures); cash is cash of ₹0.35 crore plus other bank balances of ₹16.40 crore (30 Sep 2026). Net debt and the March figures are Cityfort calculations.
- In H1 FY27 Cupid put ₹225.00 crore into non-current investments and spent ₹78.84 crore on plant and equipment, against ₹77.79 crore of operating cash flow.
- Non-current investments were ₹319.14 crore on 30 Sep 2026, mostly Baazar Style Retail shares and warrants and a GII healthcare fund, against ₹74.87 crore on 31 Mar 2026.
- Converting the remaining 56 lakh Baazar Style Retail warrants needs about ₹137.87 crore more; the board approved converting them on 11 Nov 2026.
- Trade receivables (money customers still owe) were ₹152.33 crore on 30 Sep 2026, up from ₹100.79 crore on 31 Mar 2026.
- Chairman and MD Aditya Kumar Halwasiya said on 11 Nov 2026: "We will make the Company debt-free as we go along."

## Who owns Cupid? (shareholding, Q2 FY27)

| Holder | % of shares |
| --- | --- |
| Promoters | 47.69% |
| Promoter shares pledged (% of promoter shares) | 7.64% |
| Foreign institutions (FII) | 4.69% |
| Indian institutions (DII) | 1.2% |
| Public | 46.42% |

Sources: S27, S28, S29, S30, S31, S32, S33, S34, S35, S36, S37, S38.

## What could go wrong

### Cash spent, borrowing up

Cash fell from ₹168.67 crore on 31 Mar 2026 to ₹0.35 crore on 30 Sep 2026, and borrowings rose from ₹50.97 crore to ₹107.45 crore. Converting the remaining Baazar Style Retail warrants needs about ₹137.87 crore more. [S5, S1, S6]

What to watch: Borrowings, cash and the warrant conversion in the Q3 FY27 results.

### Profit includes investment gains

Q2 FY27 other income of ₹21.11 crore included a ₹20.03 crore fair-value gain on an investment, 27.5% of the quarter's profit before tax (Cityfort calculation). Investment value changes also swung other comprehensive income by −₹42.46 crore in Q1 FY27 and +₹54.14 crore in Q2 FY27. [S5, S12, S13]

What to watch: Other income and fair-value lines in each quarter's results.

### Large tender orders

Exports depend on big institutional orders. They fell from ₹145.59 crore in FY24 to ₹93.58 crore in FY25, then rose to ₹208.13 crore in FY26. In FY24 three customers paid 54.7% of revenue as restated. [S3, S2, S1, S6]

What to watch: International sales each half year (₹112.73 crore in H1 FY27).

### Promoter pledge

7.64% of the promoter group's shares were pledged on 30 Sep 2026, all held by the chairman. A lender can sell pledged shares if a loan is not repaid. [S27]

What to watch: Pledge % in each quarter's shareholding pattern.

### Plans not yet delivered

The Palava plant moved from "late FY26" to Q3 FY27. The company's FY27 guidance relies on new store partnerships whose supplies start in Nov 2026. [S10, S6]

What to watch: Palava commissioning and sales to V2 Retail and Style Baazar.

### Regulatory record and exchange surveillance

SEBI issued a warning letter in Apr 2026 and settled a disclosure case in Dec 2024 without the company admitting or denying the findings. NSE's ASM list showed the stock in Long Term ASM Stage I on 12 Nov 2026. [S39, S2, S54]

What to watch: Further SEBI or exchange actions and the ASM list.

### Input costs and currency

The FY26 annual report names input-cost and crude-price swings and currency movements as risks; exports were 59.3% of FY26 product sales. [S1]

What to watch: Materials cost per ₹100 of revenue (₹41.4 in FY26).

## What to watch

Next: Q3 FY27 results, Date not announced yet.

- **Palava commissioning:** The company said on 11 Nov 2026 that Palava is scheduled for commissioning in Q3 FY27. Capital work in progress was ₹100.38 crore on 30 Sep 2026.
- **Borrowings and the warrant payment:** Borrowings were ₹107.45 crore and cash ₹0.35 crore on 30 Sep 2026; the remaining Baazar Style Retail warrants need about ₹137.87 crore.
- **Sales against guidance:** H1 FY27 revenue from operations was ₹342.58 crore. The company's FY27 guidance, given on 11 Nov 2026, is at least ₹880 crore.

## Sources

- S1: Annual Report FY26 (2025-26), standalone and consolidated financial statements, BRSR. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/annual_reports/AR_32115_CUPID_2025_2026_A_10433005_05102026183346.pdf (published 5 Oct 2026)
- S2: Annual Report FY25 (2024-25), standalone financial statements, BRSR. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/annual_reports/AR_28127_CUPID_2024_2025_A_4760311_02092025135122.pdf (published 2 Sep 2025)
- S3: Annual Report FY24 (2023-24), standalone financial statements, BRSR. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/annual_reports/AR_25562_CUPID_2023_2024_0309202416568.pdf (published 3 Sep 2024)
- S4: Annual Report FY23 (2022-23), standalone financial statements (zip on NSE). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/annual_reports/AR_23124_CUPID_2022_2023_31082023122522_08312023130000.zip (published 31 Aug 2023)
- S5: Q2 FY27 board outcome: unaudited standalone and consolidated results (quarter and half year to 30 Sep 2026), BSRL warrant conversion approval. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_11112026182708_Outcome_of_BM_held_on_11112026.pdf (published 11 Nov 2026)
- S6: Press release: Q2 and H1 FY27 financial results and guidance. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_11112026190931_SE_Intimation_PR_Q2H1FY27.pdf (published 11 Nov 2026)
- S7: Investor presentation H1 FY27. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_11112026203934_SE_Intimation_Investor_Presentation_Q2H1FY27.pdf (published 11 Nov 2026)
- S8: Q4 FY26 result presentation. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_15052026195150_Investor_Presentation.pdf (published 15 May 2026)
- S9: Press release: audited results FY26 (surpassed FY26 guidance). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_15052026194800_Press_Release.pdf (published 15 May 2026)
- S10: Investor presentation FY2025 (FY26 targets, Palava timeline). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_21052025183921_Investor_Presentation_FY2025.pdf (published 21 May 2025)
- S11: Q3 FY24 conference call transcript (call held 25 Jan 2024). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_30012024155937_Q3FY2024_Concall_Transcript.pdf (published 30 Jan 2024)
- S12: Results XBRL, standalone, Q2 FY27 (quarter and H1 to 30 Sep 2026, incl. balance sheet and cash flow). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1756220_11112026064430_WEB.xml (published 11 Nov 2026)
- S13: Results XBRL, standalone, Q1 FY27. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1710114_07082026065812_WEB.xml (published 7 Aug 2026)
- S14: Results XBRL, standalone, Q4 FY26 and FY26 (audited, incl. balance sheet and cash flow). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1667911_15052026064735_WEB.xml (published 15 May 2026)
- S15: Results XBRL, standalone, Q3 FY26. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1614510_30012026041342_WEB.xml (published 29 Jan 2026)
- S16: Results XBRL, standalone, Q2 FY26 (incl. H1 cash flow). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1572706_12112025072721_WEB.xml (published 12 Nov 2025)
- S17: Results XBRL, standalone, Q1 FY26. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1507196_08082025064133_WEB.xml (published 8 Aug 2025)
- S18: Results XBRL, standalone, Q4 FY25 and FY25 (audited, incl. balance sheet and cash flow). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1446220_21052025075606_WEB.xml (published 21 May 2025)
- S19: Results XBRL, standalone, Q3 FY25. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/INDAS_120956_1388043_20022025035533.xml (published 20 Feb 2025)
- S20: Results XBRL, standalone, Q2 FY25. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/INDAS_115563_1308308_13112024034153.xml (published 12 Nov 2024)
- S21: Results XBRL, standalone, Q1 FY25. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/INDAS_110436_1213533_06082024122235.xml (published 5 Aug 2024)
- S22: Results XBRL, standalone, Q4 FY24 and FY24 (audited). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/INDAS_104541_1084290_08042024081803.xml (published 8 Apr 2024)
- S23: Results XBRL, standalone, Q4 FY23 and FY23 (audited). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/INDAS_93141_855181_27052023054105.xml (published 27 May 2023)
- S24: Results XBRL, standalone, Q4 FY22 and FY22 (audited). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/INDAS_86924_670197_31052022042829_WEB.xml (published 31 May 2022)
- S27: Shareholding pattern as of 2026-09-30 (XBRL, incl. pledge). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/SHP_1740014_16102026042747_WEB.xml (published 16 Oct 2026)
- S28: Shareholding pattern as of 2026-06-30 (XBRL, incl. pledge). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/SHP_1693218_15072026041154_WEB.xml (published 15 Jul 2026)
- S29: Shareholding pattern as of 2026-03-31 (XBRL, incl. pledge). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/SHP_1646341_06042026061116_WEB.xml (published 6 Apr 2026)
- S30: Shareholding pattern as of 2025-12-31 (XBRL, incl. pledge). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/SHP_1596973_08012026062514_WEB.xml (published 8 Jan 2026)
- S31: Shareholding pattern as of 2025-09-30 (XBRL, incl. pledge). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/SHP_1553729_18102025053545_WEB.xml (published 18 Oct 2025)
- S32: Shareholding pattern as of 2025-06-30 (XBRL, incl. pledge). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/SHP_1481091_11072025053013_WEB.xml (published 11 Jul 2025)
- S33: Shareholding pattern as of 2025-03-31 (XBRL, incl. pledge). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/SHP_196358_1408959_05042025063905_WEB.xml (published 5 Apr 2025)
- S34: Shareholding pattern as of 2024-12-31 (XBRL, incl. pledge). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/SHP_194785_1346625_15012025070210_WEB.xml (published 15 Jan 2025)
- S35: Shareholding pattern as of 2024-09-30 (XBRL, incl. pledge). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/SHP_193445_1282595_21102024041234_WEB.xml (published 21 Oct 2024)
- S36: Shareholding pattern as of 2024-06-30 (XBRL, incl. pledge). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/SHP_189104_1180386_11072024045522_WEB.xml (published 11 Jul 2024)
- S37: Shareholding pattern as of 2024-03-31 (XBRL, incl. pledge). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/SHP_186565_1090410_12042024072414_WEB.xml (published 12 Apr 2024)
- S38: Shareholding pattern as of 2023-12-31 (XBRL, incl. pledge). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/SHP_184215_1021393_15012024050659_WEB.xml (published 15 Jan 2024)
- S39: SEBI administrative warning letter dated 23 Apr 2026 (Reg 30(7) LODR, non-disclosure of cancellation of preferential issue), Reg 30 intimation. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_28042026192234_Intimation_of_Administrative_Warning.pdf (published 28 Apr 2026)
- S40: Board outcome 21 Jan 2026: investment of Rs 331.53 crore in convertible warrants of Baazar Style Retail Ltd. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_21012026221050_BM_Outcome.pdf (published 21 Jan 2026)
- S43: Board in-principle approval for South African condom manufacturing venture (Cupid up to 49%). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_28082026160857_Disclosure_under_Reg_30_Inprincple_Approval.pdf (published 28 Aug 2026)
- S44: Board in-principle approval for an FMCG manufacturing facility in Saudi Arabia. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_29122025171852_BM_Outcome.pdf (published 29 Dec 2025)
- S47: Allotment of 1,07,57,28,560 bonus shares (record date 9 Mar 2026). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_10032026132357_Intimation_of_Allotment_of_Bonus_Shares.pdf (published 10 Mar 2026)
- S48: Company advisory against unauthorised "multibagger" messages. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_18022026164209_General_Updates_Investor_Cautionary_Advisory.pdf (published 18 Feb 2026)
- S49: Post-offer advertisement, open offer by Columbia Petro Chem Pvt Ltd and Aditya Halwasiya (Rs 325 per share; 41.84% acquired by agreement). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_02012024182750_CUPID.pdf (published 2 Jan 2024)
- S50: Reg 30: Supreme Court order of 26 Jul 2024 in Cupid Ltd & Ors vs Vikas Lifecare Ltd. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_30072024175306_Intimation_Reg_30.pdf (published 30 Jul 2024)
- S51: Reg 30: suit with Vikas Lifecare withdrawn after settlement (Alwar court 1 Feb 2025, Rajasthan HC 4 Feb 2025). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_12022025193621_Intimation_of_Court_Order.pdf (published 12 Feb 2025)
- S53: NSE CM bhavcopy 11 Nov 2026 (CUPID EQ close Rs 354.00). NSE (nsearchives.nseindia.com). https://nsearchives.nseindia.com/content/cm/BhavCopy_NSE_CM_0_0_0_20261111_F_0000.csv.zip (published 11 Nov 2026)
- S54: NSE Additional Surveillance Measure list (CUPID: LTASM Stage I, as of 12 Nov 2026). NSE (www.nseindia.com/reports/asm, api/reportASM). https://www.nseindia.com/reports/asm (published 12 Nov 2026)
- S55: Exchange approval (4 Dec 2024) of reclassification of outgoing promoters (Omprakash, Veena, Suresh Chand and Abha Garg) to public. NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/CUPID_04122024183217_Intimation_of_Reclassification_of_Promoters_Final.pdf (published 4 Dec 2024)
- S56: Shareholding pattern as of 8 Apr 2024 (XBRL; date of allotment 2024-04-08, after the share split and 1:1 bonus). NSE (company filing, nsearchives.nseindia.com). https://nsearchives.nseindia.com/corporate/xbrl/SHP_187635_1099398_18042024070527_WEB.xml (published 18 Apr 2024)
